Globus Medical Overview
- Founded
-
2003

- Status
-
Public
- Employees
-
2,600

- Stock Symbol
-
GMED

- Investments
-
12
- Share Price
-
$53.47
- (As of Wednesday Closing)
Globus Medical General Information
Description
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.
Contact Information
- 2560 General Armistead Avenue
- Audubon, PA 19403
- United States
Globus Medical Stock Performance
(As of Wednesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$53.47 | $53.20 | $50.92 - $81.78 | $5.34B | 100M | 1.42M | $1.89 |
Globus Medical Financials Summary
In Thousands, USD |
TTM 31-Dec-2022 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
---|---|---|---|---|
EV | 7,010,021 | 7,010,021 | 6,772,197 | 6,025,732 |
Revenue | 1,022,843 | 1,022,843 | 958,102 | 789,042 |
EBITDA | 297,038 | 297,038 | 240,978 | 174,821 |
Net Income | 190,169 | 190,169 | 149,191 | 102,285 |
Total Assets | 2,076,126 | 2,076,126 | 1,957,263 | 1,679,485 |
Total Debt | 0 | 0 | 0 | 0 |
Globus Medical Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Globus Medical Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
Globus Medical Comparisons
Industry
Financing
Details
Globus Medical Competitors (34)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
NuVasive | Pending Transaction (M&A) | San Diego, CA | 0000 | 00000 | 000000&0 | 00000 |
00000000 000000000 | Formerly PE-Backed | Lewisville, TX | 0000 | 00000000 | ||
0000000000 00000 | Formerly VC-backed | Irvine, CA | 00 | 00000 | 00000000 | 00000 |
00000 0000000 0000 | Corporation | South Jordan, UT | 0000 | 00000 | 000000000000 | |
00000 0000000 | Formerly VC-backed | Belgrade, MT | 000 | 000.00 | 000000000 | 000.00 |
Globus Medical Patents
Globus Medical Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230087783-A1 | Leveraging two-dimensional digital imaging and communication in medicine imagery in three-dimensional extended reality applications | Pending | 08-Nov-2022 | 000000000 | |
US-20230078919-A1 | Extended reality systems for visualizing and controlling operating room equipment | Pending | 16-Sep-2021 | 000000000 | |
US-20230083605-A1 | Extended reality systems for visualizing and controlling operating room equipment | Pending | 16-Sep-2021 | 000000000 | |
EP-4151171-A1 | Robot surgical platform for cranial surgery | Pending | 15-Sep-2021 | 000000000 | 0 |
US-20230083538-A1 | Robot surgical platform for cranial surgery | Pending | 15-Sep-2021 | A61B34/10 |
Globus Medical Executive Team (15)
Globus Medical Board Members (13)
Name | Representing | Role | Since |
---|---|---|---|
Ann Rhoads | Self | Board Member | 000 0000 |
Daniel Lemaitre | Globus Medical | Board Member | 000 0000 |
Daniel Scavilla | Globus Medical | Chief Executive Officer & Board Member | 000 0000 |
David Davidar | Globus Medical | Board Member | 000 0000 |
David Demski | Globus Medical | Chief Executive Officer & Board Member | 000 0000 |
Globus Medical Signals
Globus Medical Acquisitions (12)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000000 | 09-Feb-2023 | 0000000000 | 00.00 | Surgical Devices | |
00000000 0000 | 04-Nov-2021 | 0000000000 | 0000 | Surgical Devices | 00000 000 |
0000000 | 01-May-2020 | 0000000000 | 000.00 | Therapeutic Devices | |
00000000 | 01-Jun-2019 | 0000000000 | 000.00 | Therapeutic Devices | 00000 000 |
Surgimap | 05-Sep-2018 | Merger/Acquisition | 000.00 | Outcome Management (Healthcare) | 00000 000 |
Globus Medical Subsidiaries (2)
Company Name | Industry | Location | Founded |
---|---|---|---|
Synoste | Therapeutic Devices | Espoo, Finland | 2012 |
00000000 | Outcome Management (Healthcare) | New York, NY | 0000 |
Globus Medical ESG
Risk Overview
Risk Rating
Updated August, 20, 2022
30.09 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,231
Rank
Percentile

Healthcare
Industry
00 of 601
Rank
Percentile

Medical Devices
Subindustry
00 of 207
Rank
Percentile
